[go: up one dir, main page]

TW200609001A - Particulate-stabilized injectable pharmaceutical compositions of posaconasole - Google Patents

Particulate-stabilized injectable pharmaceutical compositions of posaconasole

Info

Publication number
TW200609001A
TW200609001A TW094117524A TW94117524A TW200609001A TW 200609001 A TW200609001 A TW 200609001A TW 094117524 A TW094117524 A TW 094117524A TW 94117524 A TW94117524 A TW 94117524A TW 200609001 A TW200609001 A TW 200609001A
Authority
TW
Taiwan
Prior art keywords
posaconasole
particulate
pharmaceutical compositions
injectable pharmaceutical
stabilized injectable
Prior art date
Application number
TW094117524A
Other languages
Chinese (zh)
Other versions
TWI290051B (en
Inventor
Leonore Witchey-Lakshmanan
Sydney Ugwu
Varda Sandweiss
Catherine Hardalo
Roberta S Hare
Gopal Krishna
Zaiqi Wang
Marco Taglietti
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200609001(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of TW200609001A publication Critical patent/TW200609001A/en
Application granted granted Critical
Publication of TWI290051B publication Critical patent/TWI290051B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides formulations useful for treating infections, in particular, formulations that include the active pharmaceutical ingredient posaconazole in an injectable suspension that is stable when subjected to terminal steam sterilization.
TW094117524A 2004-05-28 2005-05-27 Particulate-stabilized injectable pharmaceutical compositions of Posaconazole TWI290051B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57512604P 2004-05-28 2004-05-28

Publications (2)

Publication Number Publication Date
TW200609001A true TW200609001A (en) 2006-03-16
TWI290051B TWI290051B (en) 2007-11-21

Family

ID=34971355

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094117524A TWI290051B (en) 2004-05-28 2005-05-27 Particulate-stabilized injectable pharmaceutical compositions of Posaconazole

Country Status (15)

Country Link
EP (1) EP1761247A1 (en)
JP (1) JP2008501034A (en)
KR (1) KR20070027564A (en)
CN (1) CN1988887A (en)
AR (1) AR049063A1 (en)
AU (1) AU2005249502A1 (en)
CA (1) CA2567803A1 (en)
IL (1) IL179627A0 (en)
MX (1) MXPA06013886A (en)
NO (1) NO20066005L (en)
PE (1) PE20060291A1 (en)
RU (1) RU2006146555A (en)
TW (1) TWI290051B (en)
WO (1) WO2005117831A1 (en)
ZA (1) ZA200609890B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
AU2007250502B2 (en) 2006-05-12 2013-11-28 Christian Noe Use of combination preparations comprising antifungal agents
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2011003992A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
BR112012029227B1 (en) 2010-05-19 2020-01-07 Sandoz Ag PROCESS FOR THE PREPARATION OF A CHIRAL COMPOUND, CHIRAL COMPOUND AND USE OF A COMPOUND
BR112012029225B1 (en) 2010-05-19 2020-10-27 Sandoz Ag process for the preparation of a chiral compound, chiral compound and use of a chiral compound
CN102892762B (en) 2010-05-19 2016-04-20 桑多斯股份公司 Preparation posaconazole intermediate
MX2012013331A (en) 2010-05-19 2013-02-01 Sandoz Ag Purification of posaconazole and of posaconazole intermediates.
DK3391890T3 (en) * 2010-06-29 2021-11-01 Merck Sharp & Dohme INTRAVENOUS POSACONAZOLE SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRINE
CA2838051C (en) 2011-06-16 2019-09-24 Sandoz Ag Process for the preparation of a chiral compound
CN103284959B (en) * 2012-02-22 2015-06-03 重庆圣华曦药业股份有限公司 Posaconazole freeze-dried powder injection and preparation method thereof
CN102755628B (en) * 2012-07-16 2013-10-23 中国科学院微生物研究所 Antifungal pharmaceutical composition
CN102805731B (en) * 2012-08-22 2014-04-30 北京莱瑞森医药科技有限公司 Posaconazole dry suspension and preparation method thereof
CN105030668B (en) * 2015-06-26 2018-03-27 济川药业集团有限公司 Oral posaconazole supensoid agent and preparation method thereof
CN106333925B (en) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 A kind of posaconazole liquid suspension and preparation method thereof
CN105997872B (en) * 2016-07-08 2019-02-19 河南省立眼科医院 An ophthalmic nanomicelle antifungal solution containing posaconazole
EP3600233A4 (en) * 2017-03-26 2020-10-21 Stafford, Vivi, Robyn Method of treatment of skin conditions of eye lids
WO2018191541A1 (en) * 2017-04-12 2018-10-18 Bhagwandin Vikash J Compositions, packaged pharmaceuticals, and methods of using posaconazole for the sensitization of resistant tumors
CN110507609B (en) * 2018-05-21 2021-09-17 上海医药工业研究院 Preparation method of posaconazole oral suspension
CN111514146A (en) * 2020-04-28 2020-08-11 山西振东泰盛制药有限公司 Pharmaceutical composition containing posaconazole
CN113933131B (en) * 2021-09-24 2024-01-26 合肥天一生物技术研究所有限责任公司 Vaginal microorganism fluorescent staining solution

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
EP1372394A1 (en) * 2001-04-03 2004-01-02 Schering Corporation Antifungal composition with enhanced bioavailability

Also Published As

Publication number Publication date
RU2006146555A (en) 2008-07-20
ZA200609890B (en) 2008-09-25
CA2567803A1 (en) 2005-12-15
AR049063A1 (en) 2006-06-21
EP1761247A1 (en) 2007-03-14
TWI290051B (en) 2007-11-21
IL179627A0 (en) 2007-05-15
PE20060291A1 (en) 2006-04-14
MXPA06013886A (en) 2007-01-26
AU2005249502A1 (en) 2005-12-15
NO20066005L (en) 2007-02-27
KR20070027564A (en) 2007-03-09
WO2005117831A1 (en) 2005-12-15
CN1988887A (en) 2007-06-27
JP2008501034A (en) 2008-01-17

Similar Documents

Publication Publication Date Title
TW200609001A (en) Particulate-stabilized injectable pharmaceutical compositions of posaconasole
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
MX2009013810A (en) Use of homo- and copolymers for stabilizing active ingredient formulations.
MY143795A (en) Tetrahydropyridoindole derivatives
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
NO20080338L (en) Compounds for the treatment of multidrug-resistant bacterial infections
NO20082269L (en) NEW PIPERAZINES AS ANTIMAL ARIA AGENTS
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
EA200802135A1 (en) PHARMACEUTICAL COMPOSITIONS OF ANTAGONISTIC ANTIBODY TO CD40
EA200802203A1 (en) DIQUETOPYPERSON AND PIPERIDINE DERIVATIVES AS ANTIVIRAL AGENTS
EA200800798A1 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF DISTURBANCES OF THE INTERNAL EAR
MX2009003911A (en) Enhanced immediate release formulations of topiramate.
WO2010111640A3 (en) Anti-influenza formulations and methods
BRPI0514736A (en) sigma receptor inhibitors
EA201170680A1 (en) ACTIVE AND P70 S6 KINASE INHIBITORS
MX2009007784A (en) Compositions of stable tiacumicins.
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
IL188092A0 (en) Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
TW200640459A (en) Particulate-stabilized injectable pharmaceutical compositions of posaconazole
WO2008013823A3 (en) Co-crystals of (2r-trans)-6-chloro-5-[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n,1-trimethyl-alpha-oxo-1h-indole-3-acetamide
TW200621773A (en) Bicyclononene derivatives
MY160904A (en) Piperazines as antimalarial agents
EA200801614A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MONTELUKAST
TW200628468A (en) Bicyclononene derivatives

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees